Anupam Rasayan announced on Tuesday that it has signed a Letter of Intent (LoI) worth USD 265 million (Rs 2,186 crore) with a Japanese specialty chemical company for the supply of new age patented life science active ingredient over the next five years.
According to a regulatory filing, the company stated that the product will undergo a validation phase for the next 18 months. Following a successful validation, the supply of the product will begin from the calendar year 2025.
Anupam Rasayan Managing Director Anand Desai commented on the contract, saying, ‘We are thrilled to announce that we will be a key global supplier of this new age patented life science active ingredient to one of the leading Japanese specialty chemical companies with the support of our Japanese business development team.’
The company has achieved full backward integration for this molecule, ensuring a self-reliant supply chain for the customers. It eliminates the need for relying on supplies from other geographical regions, thus providing supply chain assurance.
As of December 31, 2022, the company possesses six manufacturing facilities in Gujarat. Out of these, four facilities are situated in Sachin, Surat, while one facility is located in Jhagadia, Bharuch, having combined installed capacity of approximately 27,200 tonnes.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.